News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

The NIH awarded more than $8.3 million to study 1,000 pregnant individuals with heart conditions in an effort to combat maternal mortality and morbidity.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

Dr. Rebecca Lobell shares what causes infertility and when a person should talk to their doctor about issues conceiving.

KCTV talked to Dr. Rebecca Lobell about infertility and the steps a woman can take when she is trying to conceive.

Saint Luke’s has been delivering babies for 135 years. To honor this anniversary, we are taking a look back at Kansas City through the decades.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Melissa Magwire talks about why diabetes is a population health problem and a unique program at Saint Luke's that is helping patients across the nation.

KCTV talked to Melissa Magwire,RN, MSN, CDE, program director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence, to learn more about the Cardiometabolic Center.

Carmon is living with type 2 diabetes, but her life is much fuller now because of the care she received at Saint Luke’s Cardiometabolic Center of Excellence.